US · Healthcare
Biotechnology
Ascendis Pharma AS (ASND) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
The price-to-earnings (P/E) ratio for Ascendis Pharma AS (ASND) is 18.00 (data as of 2026-03-23).
Dividend yield is not available in the current snapshot for Ascendis Pharma AS (ASND). Check the MyAverix Finance app for the latest dividend data.
Ascendis Pharma AS (ASND) is classified in the Healthcare sector (Biotechnology industry).
ASND is listed on US.
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.